Demystifying the Relationship Between Metformin, AMPK, and Doxorubicin Cardiotoxicity

Overview of attention for article published in Frontiers in Cardiovascular Medicine, January 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 12 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 3,235 followers.

RT @FrontCVMedicine: New Research: Demystifying the Relationship Between Metformin, AMPK, and Doxorubicin Cardiotoxicity: Doxorubicin (DOX)…

24 Jan 2022

Reply Repost Favourite

New Research: Demystifying the Relationship Between Metformin, AMPK, and Doxorubicin Cardiotoxicity: Doxorubicin (DOX) is an extremely effective and wide-spectrum anticancer drug, but its long-term use can lead to heart failure, which… https://t.co/uDyjF45

24 Jan 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.